Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device
Recruiting
N/A
Interventional Study
Hereditary Haemorrhagic Telangiectasia
PFO - Patent Foramen Ovale
Pulmonary Arteriovenous Malformation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- St. Antonius Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn how well the SONAS ultrasound device can detect right-to-left shunts of adults with hereditary hemorrhagic telangiectasia (HHT) who are already scheduled for a contrast bubble echocardiogram (TTCE). The main questions it aims to answer are:
1. How accurately does SONAS detect right-to-left shunts compared to the standard TTCE test?
2. Can SONAS results …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or older.
* Suspected or confirmed hereditary hemorrhagic telangiectasia (HHT).
* Incidentally: Patients who have experienced cryptogenic stroke
Exclusion Criteria:
* Pregnancy or breastfeeding.
* Known or suspected fracture(s) of the temporal / parietal skull b…
Contacts